||1R13CA081029-01 Interpret this number
||University Of Wisconsin Madison
||Conference-American Society of Preventive Oncology
The Primary purpose of the American Society of Preventive Oncology
(ASPO) is exchange of information about and the promotion of research
in cancer prevention and control. This application requests partial
support for the 1999 annual meeting of this small multidisciplinary
organization. In order for ASPO to provide a high quality program and
to continue to grow and increase its self-sufficiency, some level of
outside support is necessary. In recognition of ASPO's limited
resources and increasing costs for annual meetings, ASPO has established
a policy whereby invited speakers are offered an honorarium in lieu of
expenses (only) for their participation.
The 1999 meeting will be in Houston, Texas, March 14-16. Two hundred
eighty (280) participants attended the 1998 annual meeting. Speakers
and participants are from diverse disciplines involved in cancer
prevention, and most significantly from disciplines concerned with
translating known information into effective prevention programs. The
meeting will be held in the fully-accessible conference facilities of
the J. W. Marriott in Houston, Texas.
The meeting is focused on three symposia: 1) "Latest Developments in
Research on Smoking: Integrating Pharmacologic, Genetic and Behavioral
Perspectives"; 2) A Plenary Symposium: "Novel Approaches to Molecular
Detection and Chemoprevention", and 3) "Methodologic Issues in
Chemoprevention Trials". Breakfast meetings will be reserved for "late-
breaking" topics of interest to the ASPO membership. Abstracts will be
solicited for oral and poster presentation. Those abstracts receiving
the highest rankings will be published in the peer-reviewed journal,
Cancer Epidemiology, Biomarkers and Prevention. The 25 top-ranked
abstracts will be presented orally during paper sessions. Approximately
75-80 posters will be presented during the poster session. An award
will be given for the best poster. Journal advertisements, posters and
direct mail will be used to publicize the meeting.
CD34(+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells.
, Bryant E.
, Allione B.
, Vitale A.
, Foa R.
, Cheever M.A.
Blood, 1999-09-15; 94(6), p. 2048-55.